Trial Profile
Irregular vaginal bleeding with etonorgestrel contraceptive implant: a pilot randomised controlled trial of prophylactic down regulation with a gonadotrophin releasing hormone analogue [triptorelin] prior to implant insertion
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Feb 2019
Price :
$35
*
At a glance
- Drugs Triptorelin (Primary)
- Indications Vaginal bleeding
- Focus Therapeutic Use
- 31 Dec 2009 Status changed from unconfirmed to completed as reported by ISRCTN: Current Controlled Trials record.
- 27 Aug 2008 New trial record.